Regulatory

Package Case Study
|

Building products packaging meets OSHA standard

New product packaging for USG Corp.’s line of building products handily meets the deadline for OSHA’s Global Harmonization Standard, while furthering the company’s branding strategy.
E-BOOK SPECIAL REPORT
42 Best Package Designs
Sign up to receive timely updates from our editors and download this e-book consisting of our editors' picks of most notable package designs. Updated for 2014!
Column/Opinion
|

Packaging and its partners

When packagers speak of packaging, frequently they are referring to the physical structure holding a product.
Source: U.S. Food and Drug Administartion, “Pregnancy and Lactation Labeling Final Rule,” 12/3/14
News
|

FDA updates drugs/biologics labeling system

Includes major revisions on pregnancy and breastfeeding, with labeling changes taking effect June 30, 2015. Prescription drugs and biologic products approved after June 30, 2015, will use the new format immediately, while labeling for prescription drugs approved on or after June 30, 2001, will be phased in gradually.
DePuy Synthes, Stryker, Medtronic speakers highlight HealthPack 2015
News
|

DePuy Synthes, Stryker, Medtronic speakers highlight HealthPack 2015

Topics to be covered March 3-5, in Virginia Beach will include technology for manufacturing innovation, package design, sealing process validation, and a local operating nurse panel.
Column/Opinion
|

Food Contact Substance

We in the packaging industry have gotten fairly accustomed to the regulations covering packaging for food and drugs because the FDA is the regulatory body in the U.S. that covers the majority of food packaging issues.
Column/Opinion
|

An interesting rulemaking, if you like that sort of thing

In today’s column, I try to persuade you that the way FDA has lately been making regulations is unusual, surprising, and interesting.
Eric F. Greenberg is a Contributing Editor and Legal & Regulatory columnist for Packaging World and Healthcare Packaging.
Column/Opinion
|

Navigating FDA recall requirements

A medical device recall by any other name might still stink for your company.
Kevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity.
Column/Opinion
|

Reevaluating drug product stability can save millions on packaging

Kevin O’Donnell, Senior Partner, Exelsius, is a noted authority in supply chain integrity. In this Q&A he lends his “big-picture” insights regarding distribution practices for time and temperature-sensitive pharmaceutical/biological products.
FDASIA strengthens agency’s authority
News
|

FDASIA strengthens agency’s authority

Reviewing provisions of the legislation that impact drug product inspections.
GS1 US has published a guideline that details how to implement GS1 Standards to support the 2013 Drug Supply Chain Security Act (DSCSA), and enhance patient safety and security in the pharmaceutical supply chain. (This photo is for illustration purposes only.)
News
|

Guideline delineates how to implement GS1 standards

Document provides intelligence to support pharmaceutical lot-level management and future item-level traceability requirements

Pages

Subscribe to Regulatory

Newsletters

Don't miss intelligence crucial to your job and business!
Click on any newsletter to view a sample. Enter your email address below to sign up!
GENERAL INTEREST
PACKAGE DESIGN/DEVELOPMENT
Each newsletter ranges in frequency from once per month to a few times per month at most.